PACLX | RPBAX | PACLX / RPBAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 20 years | 85 years | - |
Gain YTD | 12.998 | 13.798 | 94% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 65.3B | 4.77B | 1,370% |
Annual Yield % from dividends | 1.77 | 1.95 | 91% |
Returns for 1 year | 18.82 | 21.95 | 86% |
Returns for 3 years | 1.24 | -0.00 | -33,658% |
Returns for 5 years | 28.73 | 26.66 | 108% |
Returns for 10 years | 58.23 | 43.30 | 134% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FLSCX | 41.58 | 0.38 | +0.92% |
Fidelity Advisor Leveraged Co Stk C | |||
SGRKX | 44.50 | 0.12 | +0.27% |
Allspring Growth Admin | |||
RPEBX | 63.71 | 0.10 | +0.16% |
American Funds New Perspective R2E | |||
BIPIX | 68.74 | N/A | N/A |
ProFunds Biotechnology UltraSector Inv | |||
PSVKX | 19.40 | N/A | N/A |
PGIM Quant Solutions Small-Cap Val R4 |